Innate Pharma IPHA
NASDAQ IPHA
$1.50 -0.07 (-4.46%)
At close: Oct 22, 2026 · 4:00 PM EDT

Innate Pharma (IPHA) Net Debt Issuances and Repayments (2019)

Updated

Analysis

Innate Pharma (IPHA) Net Debt Issuances and Repayments (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -2.00 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -2.46 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -17.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 64.00 Mn
10 Innate Pharma 140.58 Mn -66.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 819,132.90
API Access

Innate Pharma Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=IPHA&period=max&api_key=YOUR_API_KEY